Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
70 participants
INTERVENTIONAL
2016-03-01
2017-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia
NCT01608750
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680
Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
NCT05287633
Acotiamide vs Itopride in Postprandial Distress Syndrome
NCT07174297
Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional Dyspepsia
NCT01355276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Buspirone plus Omeprazole
Buspirone
Buspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.
Placebo plus Omeprazole
Placebo Oral Tablet
Buspirone placebo QID after meal plus 20mg omeprazole before breakfast.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buspirone
Buspirone 5mg used QID a day after meal plus 20mg omeprazole before breakfast.
Placebo Oral Tablet
Buspirone placebo QID after meal plus 20mg omeprazole before breakfast.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* normal upper endoscopy within five years
* negative Urease test for H-pylori
* acceptance informed concept form.
Exclusion Criteria
* taking other drugs for FD
* patients with the organic gastrointestinal disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meisam AbdarEsfahani
Mediacal Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
166681
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.